Agenda
OIS is being postponed due to COVID-19. Stay tuned for more details.
6:00 - 8:00 PM
Welcome Reception
7:15 - 9:05 AM
Networking Breakfast
7:45 - 8:45 AM
Breakout Sessions
Presbyopia
Company Presentations:
TBD
Participants:
Mitchell Jackson, MD, Founder & CEO - Jacksoneye
Moderated By:
Ehsan Sadri, MD, FACS, Founder & CEO - Visionary Eye Institute
Dry Eye Diagnostics
Company Presentations:
TBD
Participants:
Kenneth Beckman, MD, Director, Corneal Service - Comprehensive EyeCare of Central Ohio/Clinical Assistant Professor of Ophthalmology - The Ohio State University
Moderated By:
Marguerite McDonald, MD, FACS - OCLI (Ophthalmic Consultants of Long Island)
Refractive Correction
Company Presentations:
TBD
Participants:
Stephen Lane, MD, Chief Medical Officer, Head of Med Affairs & Medical Safety - Alcon
Moderated By:
Edward Manche, MD, Professor of Ophthalmology, Division Chief, Cornea and Refractive Surgery - Stanford University School of Medicine
Dropless Cataract Surgery: What is the Business Model and Who Pays
Company Presentations:
TBD
Participants:
Damien Goldberg, MD - Wolstan and Goldberg Eye Associates
Mark Kontos, MD, Senior Partner - Empire Eye Physicians
John McInnes, MD, JD, Counsel - Arnold & Porter
Moderated By:
Jonathan Talamo, MD, Independent Entrepreneur, Consultant, and Board Director
MIGS and Beyond: Future of Glaucoma Surgery
Company Presentations:
TBD
Participants:
TBD
Moderated By:
Ike Ahmed, MD - University of Toronto/Prism Eye Institute
Funding Ophthalmic Innovations
Participants:
Michael Keyoung, MD, PhD, Managing Director & Head, North America - CBC Group/C-Bridge Capital
Jason Tester, Chief Financial Officer - Horowitz Group
Jeffry Weinhuff, Managing Partner - Visionary Ventures
Cameron Wheeler, PhD, Partner - Deerfield Management
Moderated By:
Juliette Audet, Principal - Forbion
9:05 - 9:15 AM
Summit Kick-Off and Ophthalmic Innovation First Quarter Update
Presented By:
William J. Link, PhD, Managing Director - Flying L Partners
9:15 - 9:45 AM
Industry Leaders Perspective on Innovation
Colin Francou, Managing Director - Théa Open Innovation
Chuck Hess, VP & General Manager, US Surgical Business - Bausch + Lomb
Jehan Tamboowalla, VP, Head of New Products, Ophthalmology - Novartis
Moderated By:
William J. Link, PhD, Managing Director - Flying L Partners
9:45 - 10:27 AM
Innovation Showcase 1
10:27 - 11:00 AM
Morning Networking & Refreshment Break
11:00 - 11:42 AM
Innovation Showcase 2
11:42 - 12:15 PM
From Concept to Company - Lessons Learned from Serial Entrepreneurs
Participants:
Michael Ackermann, Chairman - Oyster Point Pharmaceuticals, Tarsus Pharmaceuticals & Presidio Medical
John Berdahl, MD - Vance Thompson Vision/ Founder & CEO – Equinox
Andy Corley, Principal - Yelroc Consulting
Eugene de Juan, MD, Vice-Chairman - ForSight Labs
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life Sciences
12:15 - 12:30 PM
Fireside Chat with the FDA's Head of Ophthalmic Devices
Participants:
Malvina Eydelman, MD, Director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices - FDA
Moderated By:
Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants/Adjunct Clinical Professor Emeritus - University of Minnesota, Department of Ophthalmology/Visiting Professor - UC Irvine Gavin Herbert Eye Institute/Trustee - University of Minnesota Foundation
12:30 - 1:20 PM
Networking Lunch
1:20 - 2:00 PM
Lacrimal Gland Vs Lids: What Should We Target in Dry Eye Disease
Company Presentations
TBD
Panel discussion
Participants:
Alice Epitropoulos, MD, FACS - Cataract & Refractive Center of Ohio
Cynthia Matossian, MD, FACS, Founder & Medical Director - Matossian Eye Associates
Joseph Tauber, MD, CEO - Tauber Eye Center
William Trattler, MD, Director of Cornea - Center For Excellence In Eye Care
Moderated By:
Kendall Donaldson, MD, Professor, Clinical Ophthalmology - Bascom Palmer Eye Institute
2:00 - 2:30 PM
The Business of Premium Cataract Surgery: Opportunities and Limits
Participants:
Shareef Mahdavi, President - SM2 Strategic/ Author - Beyond Bedside Manner
Nick Ruth, US Senior Marketing Director - Alcon Surgical
Eric Weinberg, Chief Commercial Officer - RxSight
William Wiley, MD - Cleveland Eye Clinic
Moderated By:
Vance Thompson, MD – Vance Thompson Vision
2:30 - 2:37 PM
Private and Public Markets Predictions
2:37 - 2:42 PM
OIS Index Update
Presented By:
Michael Lachman, President - EyeQ Research
2:42 - 3:24 PM
Innovation Showcase 3
3:24 - 4:04 PM
Public Showcase
4:04 - 4:45 PM
Afternoon Networking & Refreshment Break
4:45 - 5:30 PM
Pipeline Previews
Six established companies will provide attendees with a first-hand look at their late-stage, anterior segment development pipeline. The presentations will be followed by a panel of KOLs who will discuss how they see those products integrating into clinical practice.
Johnson & Johnson Vision
Pipeline Presentation
Presented By:
Xiao-Yu Song, Global Head, R&D - Johnson & Johnson Vision
KOL Discussion
Participants:
TBD
Alcon
Pipeline Presentation
Presented By:
Laurent Attias, SVP, Corporate Development Strategy, BD&L and M&A - Alcon
KOL Discussion
Participants:
TBD
Allergan
Presented By:
Michael Robinson, MD, VP, Global Therapeutic Area Head, Ophthalmology - Allergan
KOL discussion
Participants:
Damien Goldberg, MD - Wolstan and Goldberg Eye Associates
Felipe Medeiros, MD, PhD, Distinguished Professor - Duke University
Bausch + Lomb
Pipeline presentation
Presented By:
Chuck Hess, VP & General Manager, US Surgical Business - Bausch + Lomb
KOL discussion
Participants:
TBD
Novartis
Pipeline Presentation
Presented By:
TBD
KOL Discussion
Participants:
TBD
Glaukos
Pipeline presentation
Presented By:
Jane Rady, SVP, Corporate Strategy & Business Development - Glaukos Corporation
KOL discussion
Participants:
Daniel Durrie, MD, President - Durrie Consulting
Jay Katz, MD, Director, Glaucoma Service - Wills Eye Hospital/Chief Medical Officer – Glaukos
Raj Rajpal, MD, Founder - See Clearly Vision Group
Paul Singh, MD - Eye Centers of Racine & Kenosha